Related content

Treatment of Interstitial Lung Disease Associated with Polymyositis- Dermatomyositis: An Update

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 2, 2013-01 ,pp. : 130-136

Bentham Science Publishers

Access to resources Recommend Favorite

Interstitial Lung Disease Associated with Polymyositis-Dermatomyositis

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 221-228

Bentham Science Publishers

Access to resources Recommend Favorite

Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

By Arai Satoko   Kurasawa Kazuhiro   Maezawa Reika   Owada Takayoshi   Okada Harutsugu   Fukuda Takeshi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 872-883

Springer Publishing Company

Access to resources Recommend Favorite

Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis

By Vencovský J   Jarošová K   Macháček S   Studýnková J   Kafková J   Bartuňková J   Němcová D   Charvát F  

Scandinavian Journal of Rheumatology, Vol. 29, Iss. 2, 2000-05 ,pp. : 95-102

Informa Healthcare

Access to resources Recommend Favorite

Interstitial lung disease in polymyositis and dermatomyositis

By Chen I-Jung   Jan Wu Yeong-Jian   Lin Cho-Wei   Fan Kang-Wei   Luo Shue-Fen   Ho Huei-Huang   Liou Lieh-Bang   Tsai Wen-Pin   Chen Ji-Yih   Yang Chung-Han   Kuo Chang-Fu   Yu Kuang-Hui  

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 639-646

Springer Publishing Company

Access to resources Recommend Favorite